Skip to Content

Ansell Ltd ANN

Morningstar Rating
A$25.42 +0.21 (0.83%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Narrow-Moat Ansell's Long-Term Trajectory Is Intact

Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently held the highest or second-highest global market share in its key verticals. Competitors differ between the two segments but are either divisions of large global players or regional companies. Key industrial competitors are Honeywell, Globus, a private UK company, and ATG Gloves in the US In the healthcare segment, Halyard Health (spun out of Kimberly Clark in 2014) and Cardinal Health are major players.

Price vs Fair Value

ANN is trading within a range we consider fairly valued.
Price
A$25.21
Fair Value
A$54.00
Uncertainty
Medium
1-Star Price
A$98.80
5-Star Price
A$36.90
Economic Moat
Mgwlsdv
Capital Allocation
Fpkbdhwxw

Bulls Say, Bears Say

Bulls

The fruits of Ansell’s restructuring efforts, being improved organic growth and expanding margins, started to become evident prepandemic in the first half of fiscal 2020.

Bears

Cost pressures, as well as manufacturing and supply chain disruptions are lingering with the threat of continued surges in covid-19.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
A$25.21
Day Range
A$24.9025.55
52-Week Range
A$21.0027.91
Bid/Ask
A$25.25 / A$25.48
Market Cap
A$3.71 Bil
Volume/Avg
186,991 / 443,340

Key Statistics

Price/Earnings (Normalized)
21.83
Price/Sales
1.36
Dividend Yield (Trailing)
2.60%
Dividend Yield (Forward)
2.60%
Total Yield
4.07%

Company Profile

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
46,758

Competitors

Valuation

Metric
ANN
CHD
HON
Price/Earnings (Normalized)
21.8332.7421.37
Price/Book Value
1.416.388.03
Price/Sales
1.364.463.65
Price/Cash Flow
10.0224.6821.72
Price/Earnings
ANN
CHD
HON

Financial Strength

Metric
ANN
CHD
HON
Quick Ratio
0.860.611.18
Current Ratio
2.111.081.66
Interest Coverage
7.379.729.46
Quick Ratio
ANN
CHD
HON

Profitability

Metric
ANN
CHD
HON
Return on Assets (Normalized)
4.13%9.78%9.52%
Return on Equity (Normalized)
6.66%21.27%35.30%
Return on Invested Capital (Normalized)
5.67%14.61%16.16%
Return on Assets
ANN
CHD
HON
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncRwnhjdcsqjXmd$142.2 Bil
BDX
Becton Dickinson & CoKkbtpnjzYnkxg$67.8 Bil
ALC
Alcon IncPvzscnmHtmjnw$44.6 Bil
RMD
ResMed IncYtwmqllrthRcnmzm$32.1 Bil
CLPBY
Coloplast A/S ADRLyxdvsxjfvPmvrc$28.0 Bil
WST
West Pharmaceutical Services IncRgxjfrcvwPxr$24.5 Bil
COO
The Cooper Companies IncXcsmnzwqMbdhk$19.2 Bil
BAX
Baxter International IncTzznbbfyYkkwd$17.5 Bil
HOLX
Hologic IncLrbgflxphJbmhwq$17.5 Bil
TFX
Teleflex IncQsxbwCgt$10.3 Bil

Sponsor Center